General Info

Mahdi Taha, DO, FACOI, FACP earned his medical degree from New York College of Osteopathic Medicine in Old Westbury, NY. After completing his residency in internal medicine at the Oklahoma State University Medical Center in Tulsa, OK, he was awarded a fellowship at Cancer Treatment Centers of America through Oklahoma State University, where he was named medical oncology chief fellow. Prior to joining FCS, Dr. Taha volunteered for the American Red Cross Haiti Disaster Relief, where he cared for patients in Port-Au-Prince. After returning from Haiti, he worked as an associate medical director at Octapharma Plasma Center, Inc. in Atlanta, GA, an adjunct clinical professor for the Morehouse School of Medicine in Atlanta, GA and the lead medical oncologist at the Cancer Treatment Centers of America and Research Center. In 2019, Dr. Taha received the Georgia Trend Magazine “40 Under 40 for 2019” award and the Castle Connolly Top Doctor Award in 2018, 2019 and 2020. Dr. Taha has a strong interest in research with a focus in Head and Neck Cancer as well as Thoracic Oncology, ImmunoOncology, Genitourinary Oncology including Prostate Cancer and Renal Cell Carcinoma. He has served on various research committees and participated as principal investigator during several clinical trial studies. Dr. Taha has given presentations at conferences such as the ACOI National Convention Case Presentation in San Antonio, Texas, which won the First Place National Award and is a medical consultant for Eisai Pharmaceuticals, Novartis Pharmaceuticals, CBS – “Atlanta Plugged In,” Genentech BioOncology and Merck Pharmaceutical Inc.